These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8757473)

  • 1. Heterotopic bone formation in the gastrointestinal tract.
    Haque S; Eisen RN; West AB
    Arch Pathol Lab Med; 1996 Jul; 120(7):666-70. PubMed ID: 8757473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterotopic bone formation in two cases of colon carcinoma.
    Alper M; Akyürek N; Patiroğlu TE; Yüksel O; Belenli O
    Scand J Gastroenterol; 2000 May; 35(5):556-8. PubMed ID: 10868462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus.
    Buskens CJ; Hulscher JB; van Gulik TM; Ten Kate FJ; van Lanschot JJ
    J Surg Res; 2006 Oct; 135(2):337-44. PubMed ID: 16926029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
    Yacoub L; Goldman H; Odze RD
    Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of recurrent specialized intestinal metaplasia after complete laser ablation.
    Fisher RS; Bromer MQ; Thomas RM; Cohen S; Krevsky B; Horwitz B; Glazier KD; Das K; Das KM
    Am J Gastroenterol; 2003 Sep; 98(9):1945-51. PubMed ID: 14499770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetic acid-enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett's oesophagus.
    Fortun PJ; Anagnostopoulos GK; Kaye P; James M; Foley S; Samuel S; Shonde A; Badreldin R; Campbell E; Hawkey CJ; Ragunath K
    Aliment Pharmacol Ther; 2006 Mar; 23(6):735-42. PubMed ID: 16556175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterotopic gastric mucosa of the gastrointestinal tract: a histopathologic study of 158 cases.
    Terada T
    Pathol Res Pract; 2011 Mar; 207(3):148-50. PubMed ID: 21242038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterotopic ossification in appendiceal mucinous neoplasms: clinicopathological characteristics of 3 cases.
    Choi SY; Park S; Kim KH; Kim SH
    Malays J Pathol; 2016 Apr; 38(1):49-54. PubMed ID: 27126665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
    Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
    Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in Barrett's esophagus: short-segment Barrett's esophagus and cardia intestinal metaplasia.
    Sharma P
    Semin Gastrointest Dis; 1999 Jul; 10(3):93-102. PubMed ID: 10435696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
    Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
    Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal approach to obtaining mucosal biopsies for assessment of inflammatory disorders of the gastrointestinal tract.
    Yantiss RK; Odze RD
    Am J Gastroenterol; 2009 Mar; 104(3):774-83. PubMed ID: 19209164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Glassy" cells in Barrett's mucosa.
    Rubio CA
    Anticancer Res; 2009 Oct; 29(10):4145-6. PubMed ID: 19846963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus.
    Ragunath K; Krasner N; Raman VS; Haqqani MT; Cheung WY
    Endoscopy; 2003 Dec; 35(12):998-1003. PubMed ID: 14648410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia.
    Mohammed IA; Streutker CJ; Riddell RH
    Mod Pathol; 2002 Jun; 15(6):611-6. PubMed ID: 12065774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of short segment Barrett's esophagus with intestinal metaplasia in stomach.
    Tuncer I; Ugraş S; Uygan I; Türkdoğan K; Kösem M
    Turk J Gastroenterol; 2003 Mar; 14(1):33-8. PubMed ID: 14593535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas.
    Regalado SP; Nambu Y; Iannettoni MD; Orringer MB; Beer DG
    Mol Carcinog; 1998 Jul; 22(3):182-9. PubMed ID: 9688144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.